Literature DB >> 11376385

Fever and granulocytopenia in children with acute lymphoblastic leukemia under induction therapy.

H M Meir1, I A Balawi, H M Meer, H Nayel, M F Al-Mobarak.   

Abstract

OBJECTIVE: Infection is one of the most serious complications of cancer therapy. The rationale of using broad spectrum antibiotics prophylactically has led to a great change in the causative organisms. The aim of the present study is to review retrospectively the type and sequence of infectious complications among Saudi children with acute lymphoblastic leukemia.
METHODS: A total of 233 febrile episodes were observed in 137 children with acute lymphoblastic leukemia under induction therapy using modified BFM protocol were studied.
RESULTS: Profound neutropenia (Absolute Neutrophil count < 100/mm3) was encountered in 72 episodes (31%). Clinical signs and symptoms suggestive of infection were evident in 39% of the neutropenic episodes. The respiratory system was the most frequently affected site encountered in 17% of the episodes. Microbiologically documented infection was recorded in 59% (n=137) of the fever and granulocytopenia episodes. In 96 episodes (41%), there was neither clinical nor microbiological evidence of infection fever of unknown origin. Out of the 932 cultures, positive isolates were detected in 346 cultures (37%). Gram positive cocci were the most frequently organisms (54%) followed by gram negative bacilli (39%). In the current study, 7 patients (3%) died because of direct or indirect consequences of infection.
CONCLUSION: The current study stresses the importance of frequent reviewing of the type, frequency, severity and outcome of infection complications over years to detect changing epidemiological patterns.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11376385

Source DB:  PubMed          Journal:  Saudi Med J        ISSN: 0379-5284            Impact factor:   1.484


  7 in total

1.  Infections in a pediatric patient cohort with acute lymphoblastic leukemia during the entire course of treatment.

Authors:  Katerina Katsimpardi; Vassilios Papadakis; Anastasia Pangalis; Agapi Parcharidou; John P Panagiotou; Michael Soutis; Evangelos Papandreou; Sophia Polychronopoulou; Stavros Haidas
Journal:  Support Care Cancer       Date:  2005-11-04       Impact factor: 3.603

2.  Bloodstream infections exacerbate incidence and severity of symptomatic glucocorticoid-induced osteonecrosis.

Authors:  Emily R Finch; Laura J Janke; Colton A Smith; Seth E Karol; Deqing Pei; Cheng Cheng; Sue C Kaste; Hiroto Inaba; Ching-Hon Pui; Joshua Wolf; Mary V Relling
Journal:  Pediatr Blood Cancer       Date:  2019-02-13       Impact factor: 3.167

3.  Varicella-zoster virus infections in immunocompromised patients - a single centre 6-years analysis.

Authors:  Verena Wiegering; Judith Schick; Meinrad Beer; Benedikt Weissbrich; Stefan Gattenlöhner; Hermann J Girschick; Johannes Liese; Paul G Schlegel; Matthias Eyrich
Journal:  BMC Pediatr       Date:  2011-05-10       Impact factor: 2.125

4.  Bacterial bloodstream infections and antimicrobial susceptibility pattern in pediatric hematology/oncology patients after anticancer chemotherapy.

Authors:  Naima A Al-Mulla; Saad J Taj-Aldeen; Sittana El Shafie; Mohammed Janahi; Abdullah A Al-Nasser; Prem Chandra
Journal:  Infect Drug Resist       Date:  2014-11-06       Impact factor: 4.003

5.  Bacterial Spectrum, Isolation Sites and Susceptibility Patterns of Pathogens in Adult Febrile Neutropenic Cancer Patients at a Specialist Hospital in Saudi Arabia.

Authors:  Mansoor Sirkhazi; Azmi Sarriff; Noorizan Abd Aziz; Fatma Almana; Osama Arafat; Mahmoud Shorman
Journal:  World J Oncol       Date:  2014-12-03

6.  Role of kif2c, A Gene Related to ALL Relapse, in Embryonic Hematopoiesis in Zebrafish.

Authors:  Chang-Kyu Oh; Ji Wan Kang; Yoonsung Lee; Kyungjae Myung; Mihyang Ha; Junho Kang; Eun Jung Kwon; Youngjoo Kim; Sae-Ock Oh; Hye Jin Heo; Shin Kim; Yun Hak Kim
Journal:  Int J Mol Sci       Date:  2020-04-28       Impact factor: 5.923

7.  Varicella-Zoster Virus Infections in Pediatric Malignancy Patients: A Seven-Year Analysis.

Authors:  Mine Düzgöl; Gülcihan Özek; Nuri Bayram; Yeşim Oymak; Ahu Kara; Bengü Demirağ; Tuba Hilkay Karapınar; Yılmaz Ay; Canan Vergin; İlker Devrim
Journal:  Turk J Haematol       Date:  2016-10-18       Impact factor: 1.831

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.